品牌现货直购
供应商:我要出现这里

查看所有供应商和价格请点击:

483-18-1生产厂家

483-18-1价格

483-18-1

483-18-1结构式
483-18-1结构式

化源商城直购

中文名 依米丁
英文名 emetine
英文别名 EMETINE
Emetine hydrochloride
(2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
Emetine [BAN]
Emetin
Cephaline-O-methyl ether
Emetan,6',7',10,11-tetramethoxy
10,11,6',7'-tetramethoxy-emetane
Methyl cephaeline
Cephaeline methyl ether
描述 Emetine 是一种抗原虫药,早期用于治疗肠道和组织的阿米巴病。
相关类别
体外研究 据报道,Emetine对药物敏感的3D7恶性疟原虫寄生虫菌株的IC50值为1 nM。使用K1抗性分离物测定两种药物的剂量-反应曲线,并分别为依米丁和DHA建立47nM和2.6nM的IC 50值[1]。用emetine处理淋巴母细胞后,通过直接测序相应的cDNA,突变等位基因的表达水平几乎与野生型等位基因相同[2]。依米丁被鉴定为先导化合物,其具有显着的PEDF诱导的TNF分泌的浓度依赖性抑制和146nM的IC 50。依米丁抑制PEDF介导的TNF释放而不影响细胞活力,并以高结合亲和力(KD=14.3nM)与PEDF受体ATGL结合[3]。依米丁降低细胞活力,诱导细胞凋亡,促使AML细胞分化并下调HIF-1α[4]。
体内研究 依米丁(0.002,0.02,0.2和2mg/kg)不仅以剂量依赖性方式减弱血糖水平,而且还诱导血糖水平的持续减弱。每日施用依米丁剂量依赖性地减弱d 21的高血糖反应。与该观察结果一致,施用依米丁而非载体对照导致血糖水平的持续减弱。依米丁可改善NOD T1D自发模型中的疾病严重程度[3]。Emetine(1 mg/kg)可降低体内异种移植小鼠模型中的白血病负荷和治疗后白血病细胞的克隆形成能力[4]。
参考文献

[1]. Matthews H, et al. Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate. Malar J. 2013 Oct 9;12:359

[2]. Wu L, et al. PRRT2 truncated mutations lead to nonsense-mediated mRNA decay in Paroxysmal Kinesigenic Dyskinesia. Parkinsonism Relat Disord. 2014 Dec;20(12):1399-404

[3]. Hudson LK, et al. Emetine Di-HCl attenuates Type 1 diabetes mellitus in mice. Mol Med. 2016 Jun 10;22

[4]. Cornet-Masana JM, et al. Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells. Oncotarget. 2016 Apr 26;7(17):23239-50

密度 1.17g/cm3
沸点 600.3ºC at 760mmHg
熔点 89-96ºC
分子式 C29H40N2O4
分子量 517.10000
闪点 316.9ºC
精确质量 516.27500
PSA 52.19000
LogP 6.01210

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DK1750000
CHEMICAL NAME :
2H-Benzo(a)quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-((1, 2,3,4- tetrahydro-6,7-dimethoxy-1-isoquinolyl)methyl)-
CAS REGISTRY NUMBER :
483-18-1
LAST UPDATED :
199612
DATA ITEMS CITED :
18
MOLECULAR FORMULA :
C29-H40-N2-O4
MOLECULAR WEIGHT :
480.71
WISWESSER LINE NOTATION :
T B666 GNTT&J E2 LO1 MO1 D1- BT66 CMT&J HO1 IO1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Rinsed with water
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
10 mg/kg/10D
TOXIC EFFECTS :
Behavioral - muscle weakness Cardiac - arrhythmias (including changes in conduction) Gastrointestinal - other changes
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
2941 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
8 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
7 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
25 mg/kg
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 60,1049,1978 *** REVIEWS *** TOXICOLOGY REVIEW CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year: 2,159,1973 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4638 No. of Facilities: 7 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 103 (estimated) No. of Female Employees: 52 (estimated)

危险品运输编码 UN 1544
包装等级 III
危险类别 6.1(b)
上游产品  0

下游产品  5